Broillet-Olivier E, Wenger Y, Gilliand N, Cadas H, Sabatasso S, Broillet M
Int J Mol Sci. 2024; 25(23).
PMID: 39684883
PMC: 11642283.
DOI: 10.3390/ijms252313173.
Gentilotti E, Gorska A, Cecchini M, Mirandola M, Meroi M, De Nardo P
Sci Rep. 2024; 14(1):20951.
PMID: 39251830
PMC: 11384755.
DOI: 10.1038/s41598-024-71475-3.
Alkanat H, Arslan S
Health Expect. 2024; 27(2):e14018.
PMID: 38494992
PMC: 10945215.
DOI: 10.1111/hex.14018.
Aedo-Sanchez C, Gutierrez G, Aguilar-Vidal E
Audiol Neurootol. 2023; 29(2):81-87.
PMID: 37703853
PMC: 11412481.
DOI: 10.1159/000533448.
Levesque-Boissonneault C, Bussiere N, Roy-Cote F, Cloutier F, Caty M, Frasnelli J
Chem Senses. 2023; 48.
PMID: 37586396
PMC: 10746307.
DOI: 10.1093/chemse/bjad033.
Text-based predictions of COVID-19 diagnosis from self-reported chemosensory descriptions.
Li H, Gerkin R, Bakke A, Norel R, Cecchi G, Laudamiel C
Commun Med (Lond). 2023; 3(1):104.
PMID: 37500763
PMC: 10374642.
DOI: 10.1038/s43856-023-00334-5.
Longitudinal Association of COVID-19 Hospitalization and Death with Online Search for Loss of Smell or Taste.
Toomre D, Kandula S, Shaman J
Emerg Infect Dis. 2023; 29(8):1711-1713.
PMID: 37486228
PMC: 10370832.
DOI: 10.3201/eid2908.230071.
Short Communication: Stellate Ganglion Blockade for Persistent Olfactory and Gustatory Symptoms Post-COVID-19.
Galvin V, Cheek D, Zhang Y, Collins G, Gaskin D
Local Reg Anesth. 2023; 16:25-30.
PMID: 37162813
PMC: 10164395.
DOI: 10.2147/LRA.S402197.
Olfactory impairment in COVID-19: Two methods for the assessment of olfactory function.
Tao A, Shi L, Wang Y, Duo Z, Zhao X, Mao H
Heliyon. 2023; 9(3):e14104.
PMID: 36890807
PMC: 9979703.
DOI: 10.1016/j.heliyon.2023.e14104.
The effects of comorbidities on the change of taste and smell in COVID-19 patients.
Chen J, Mi B, Yan M, Wang Y, Zhu K, Yu C
Laryngoscope Investig Otolaryngol. 2023; 8(1):25-33.
PMID: 36846410
PMC: 9948579.
DOI: 10.1002/lio2.1012.
Exploring the Social Trend Indications of Utilizing E-Commerce during and after COVID-19's Hit.
Fakieh B, Happonen A
Behav Sci (Basel). 2023; 13(1).
PMID: 36661577
PMC: 9854872.
DOI: 10.3390/bs13010005.
Construction and validation of a COVID-19 pandemic trend forecast model based on Google Trends data for smell and taste loss.
Chen J, Mi H, Fu J, Zheng H, Zhao H, Yuan R
Front Public Health. 2022; 10:1025658.
PMID: 36530657
PMC: 9751448.
DOI: 10.3389/fpubh.2022.1025658.
Metabolic dyshomeostasis induced by SARS-CoV-2 structural proteins reveals immunological insights into viral olfactory interactions.
Lachen-Montes M, Mendizuri N, Ausin K, Echaide M, Blanco E, Chocarro L
Front Immunol. 2022; 13:866564.
PMID: 36159830
PMC: 9492993.
DOI: 10.3389/fimmu.2022.866564.
Loss of olfactory sensitivity is an early and reliable marker for COVID-19.
Iravani B, Arshamian A, Lundstrom J
Chem Senses. 2022; 47.
PMID: 36069508
PMC: 9450173.
DOI: 10.1093/chemse/bjac022.
Comparative symptomatology of infection with SARS-CoV-2 variants Omicron (B.1.1.529) and Delta (B.1.617.2) from routine contact tracing data in England.
Ekroth A, Patrzylas P, Turner C, Hughes G, Anderson C
Epidemiol Infect. 2022; 150:e162.
PMID: 35975466
PMC: 9509793.
DOI: 10.1017/S0950268822001297.
Elevated plasma level of the glycolysis byproduct methylglyoxal on admission is an independent biomarker of mortality in ICU COVID-19 patients.
Alomar F, Alshakhs M, Abohelaika S, Almarzouk H, AlMualim M, Al-Ali A
Sci Rep. 2022; 12(1):9510.
PMID: 35680931
PMC: 9178541.
DOI: 10.1038/s41598-022-12751-y.
Post-COVID-19 Impairment of the Senses of Smell, Taste, Hearing, and Balance.
Ludwig S, Schell A, Berkemann M, Jungbauer F, Zaubitzer L, Huber L
Viruses. 2022; 14(5).
PMID: 35632590
PMC: 9145380.
DOI: 10.3390/v14050849.
An olfactory self-test effectively screens for COVID-19.
Snitz K, Honigstein D, Weissgross R, Ravia A, Mishor E, Perl O
Commun Med (Lond). 2022; 2:34.
PMID: 35603293
PMC: 9053292.
DOI: 10.1038/s43856-022-00095-7.
The autumnal lockdown was not the main initiator of the decrease in SARS-CoV-2 circulation in France.
Pereda-Loth V, Pineda A, Tisseyre L, Courtade-Saidi M, Bousquet C, Ferdenzi C
Commun Med (Lond). 2022; 1:7.
PMID: 35602231
PMC: 9053270.
DOI: 10.1038/s43856-021-00002-6.
Prediction of SARS-CoV-2 infection with a Symptoms-Based model to aid public health decision making in Latin America and other low and middle income settings.
Ramirez Varela A, Moreno Lopez S, Contreras-Arrieta S, Tamayo-Cabeza G, Restrepo-Restrepo S, Sarmiento-Barbieri I
Prev Med Rep. 2022; 27:101798.
PMID: 35469291
PMC: 9020649.
DOI: 10.1016/j.pmedr.2022.101798.